You are viewing: US Artificial Intelligence (AI) in Medical Diagnostics Market analysis

The US Artificial Intelligence (AI) in Medical Diagnostics Market was valued at $588.1 Million in 2024 and projected to reach to $1677.4 Million by 2029, representing a compound annual growth rate of 23.3%. The US AI in Medical Diagnostics Market is poised for sustained growth through 2029, driven by increasing adoption across hospitals, imaging centers, and clinical laboratories.

US Artificial Intelligence (AI) in Medical Diagnostics Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Artificial Intelligence (AI) in Medical Diagnostics Market Trends and Insights

  • The US market is driven by increasing adoption of AI-powered diagnostic tools across hospitals, imaging centers, and clinical laboratories, supported by substantial healthcare IT investments and regulatory frameworks favoring innovation.
  • The US leads in AI diagnostic deployment due to advanced healthcare infrastructure, high patient volumes, and strong reimbursement mechanisms that incentivize technology adoption. Growth in the US market is accelerated by rising demand for early disease detection, labor shortages in radiology and pathology, and integration of machine learning algorithms into existing diagnostic workflows.
  • The US healthcare system's emphasis on precision medicine and value-based care creates favorable conditions for AI diagnostic solutions.
  • Between 2024 and 2029, the US market is expected to nearly triple, reflecting the region's commitment to digital health transformation and competitive advantage in medical technology innovation..

Key Market Statistics

  • CAGR (2024-2029) 23.3% CAGR
  • Market Size, 2024 ~USD 588.1 Million
  • Forecast, 2029 ~USD 1677.4 Million
  • Country US

US Artificial Intelligence (AI) in Medical Diagnostics Market Overview

Market Valuation Growth :

The US AI in Medical Diagnostics Market is valued at $588.1 million in 2024, with a robust CAGR of 23.3%, projected to reach $1,677.4 million by 2029, representing a 185% increase over five years.

Healthcare IT Investment Surge :

US hospitals and imaging centers are significantly increasing investments in AI-powered diagnostic tools, driven by the need to improve diagnostic accuracy, reduce operational costs, and enhance patient outcomes across major healthcare systems.

Regulatory Framework Support :

The FDA and CMS have established favorable regulatory pathways for AI diagnostic solutions in the US, accelerating market adoption and enabling faster commercialization of innovative AI-based medical imaging and laboratory diagnostic platforms.

Clinical Laboratory Expansion :

US clinical laboratories are rapidly integrating AI algorithms for pathology analysis, genetic testing, and disease detection, with major diagnostic companies deploying machine learning solutions to streamline workflows and improve diagnostic precision.

US Artificial Intelligence (AI) in Medical Diagnostics Market Dynamics

  • Healthcare providers are prioritizing AI solutions to enhance diagnostic accuracy, reduce turnaround times, and optimize resource allocation.
  • The convergence of advanced computing infrastructure, large-scale healthcare data availability, and supportive regulatory frameworks positions the US as a leading market for AI diagnostic innovation. Key growth catalysts include rising demand for early disease detection, integration of AI with electronic health records (EHR) systems, and partnerships between technology companies and healthcare providers.
  • Investment in AI talent and infrastructure, combined with reimbursement model evolution, will further accelerate market penetration.
  • The US market's maturity and healthcare spending capacity ensure continued expansion and technological advancement in AI-driven diagnostic solutions..

Related Ecosystem

Healthcare It

Top Technologies
  • Computed Tomography (CT)
  • Machine Learning
  • Magnetic Resonance Imaging (MRI)
  • Natural Language Processing (NLP)
  • Predictive Analytics
Top Companies
  • CERNER CORPORATION
  • PHILIPS HEALTHCARE
  • Oracle Corporation
  • GE HealthCare Technologies Inc.
  • Siemens healthineers

    Diagnostic Imaging

    Top Technologies
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • CT Scanners
    • Nuclear Imaging
    • Positron Emission Tomography
    Top Companies
    • Siemens healthineers
    • PHILIPS HEALTHCARE
    • CANON INC.
    • FUJIFILM Holdings Corporation
    • UNITED IMAGING HEALTHCARE CO., LTD.

      Key Takeaways

      • The US AI in Medical Diagnostics Market will grow from $588.1M (2024) to $1,677.4M (2029), representing a 23.3% CAGR.
      • The US market benefits from advanced healthcare infrastructure, strong regulatory support, and high reimbursement rates for AI-enabled diagnostic solutions.
      • Labor shortages in radiology and pathology specialties are driving US adoption of AI diagnostic tools to improve efficiency and diagnostic accuracy.
      • The US market's growth is supported by increasing integration of AI algorithms into existing clinical workflows and emphasis on precision medicine initiatives.

      Artificial Intelligence (AI) in Medical Diagnostics Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment SERVICES (Component)
      Forecast Period 2024-2029
      Growth Rate CAGR of 22.5% from 2024 to 2029
      Largest Segment IN VIVO DIAGNOSTICS (Application)
      Market Size Base Year (Billions) ~USD 1.71 (2024)
      Revenue Forecast (Billions) ~USD 4.72 (2029)
      Segments Covered Component, Type, End User, Modality, Modality Type, Application, Type 2023-2029, Processor Type, Network Type, Type 2017-2022, Segment

      US Artificial Intelligence (AI) in Medical Diagnostics Market Report Segmentation

      11 segment dimensions are covered across the global market.

      By Component

      • Hardware
      • Services
      • Software

      By Type

      • Adapter
      • Adapters
      • Asic
      • Autoimmune Testing
      • Blood Screening & Coagulation
      • Cardiology
      • Clinical Chemistry
      • Ct
      • Diagnostic Software
      • Endocrinology
      • Fpga
      • Gpu
      • Hematology
      • Imaging Software
      • Immunoassay
      • Infectious Disease
      • Interconnect
      • Interconnects
      • Mammography
      • Memory
      • Microbiology
      • Mpu
      • Mri
      • Network
      • Networks
      • Neurology
      • Obstetrics/Gynecology
      • Oncology
      • Ophthalmology
      • Other Diagnostic Modalities
      • Other Imaging Modalities
      • Other In Vitro Applications
      • Other In Vitro Diagnostics Applications
      • Other In Vivo Applications
      • Other In Vivo Diagnostics Applications
      • Predictive Analytics
      • Predictive Analytics Software
      • Processor
      • Processors
      • Radiology
      • Switch
      • Switches
      • Ultrasound
      • X Ray
      • X-Ray

      By End User

      • Diagnostic Imaging Centers
      • Diagnostic Laboratories
      • Hospitals
      • Other End Users

      By Modality

      • Clinical Chemistry
      • Diagnostic Modalities
      • Diagnostics Modality
      • Hematology
      • Imaging Modalities
      • Imaging Modality
      • Immunoassay
      • Microbiology
      • Other Diagnostic Modalities

      By Modality Type

      • Ct
      • Mammography
      • Mri
      • Other Modalities
      • Ultrasound
      • X-Ray

      By Application

      • In Vitro Diagnostics
      • In Vitro Diagnostics Applications
      • In Vivo Diagnostics
      • In Vivo Diagnostics Applications

      By Type 2023-2029

      • Cardiology
      • Neurology
      • Obstetrics/ Gynecology
      • Oncology
      • Ophthalmology
      • Other In Vivo Applications
      • Radiology

      By Processor Type

      • Asic
      • Fpga
      • Gpu
      • Mpu

      By Network Type

      • Adapter
      • Interconnect
      • Switch

      By Type 2017-2022

      • Cardiology
      • Neurology
      • Obstetrics/Gynecology
      • Oncology
      • Ophthalmology
      • Other In Vivo Applications
      • Radiology

      By Segment

      • Hardware Component

      US: ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2023–2029

      Segment2023202420252026202720282029CAGR (%)
      DIAGNOSTIC IMAGING CENTERS105.3130.8164.1202.8247.4297.3353.322
      DIAGNOSTIC LABORATORIES30.136.545.255.366.778.992.420.4
      HOSPITALS316.2399.7510.4642.1797976.11181.224.2
      OTHER END USERS22.827.533.740.848.756.865.719.1
      TOTAL474.4594.4753.59411159.81409.11692.723.3

      Target Audience

      • Healthcare IT Vendors & Software Companies : Need detailed US market sizing and growth projections to prioritize product development investments, allocate sales resources, and establish realistic revenue targets for AI diagnostic platform launches in the American healthcare market.
      • Hospital Systems & Healthcare Providers : Require market intelligence on AI diagnostic solution capabilities, vendor benchmarking, and ROI metrics specific to US healthcare settings to make informed procurement decisions and optimize diagnostic operations.
      • Medical Device & Imaging Equipment Manufacturers : Need US market forecasts and adoption trends to guide product roadmap development, identify integration opportunities with AI technologies, and understand competitive positioning in American diagnostic imaging and laboratory markets.
      • Private Equity & Investment Firms : Seek comprehensive US market analysis to evaluate investment opportunities in AI diagnostic startups and established companies, assess market growth potential, and identify acquisition targets with strong US market positioning.
      • Healthcare Consultants & Strategy Advisors : Require validated US market data and trend analysis to support client advisory engagements, develop digital transformation roadmaps, and provide evidence-based recommendations for healthcare organizations adopting AI diagnostic solutions.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise US market valuation ($588.1M in 2024) and verified CAGR of 23.3% through 2029, enabling accurate financial forecasting and investment decision-making for stakeholders in the US healthcare AI sector.
      • Competitive Landscape Intelligence : Understand the US-specific competitive dynamics, key players, and market consolidation trends to identify partnership opportunities, acquisition targets, and differentiation strategies within the American medical diagnostics AI ecosystem.
      • Regulatory & Reimbursement Insights : Access detailed analysis of FDA approval pathways, CMS reimbursement models, and US healthcare policy frameworks that directly impact AI diagnostic solution commercialization and market entry strategies.
      • Segment & Application Analysis : Gain granular insights into US market segments by diagnostic modality (imaging, pathology, genomics), healthcare setting (hospitals, labs, clinics), and clinical applications to identify high-growth opportunities and target markets.
      • Strategic Planning & Risk Mitigation : Leverage comprehensive US market data to develop evidence-based go-to-market strategies, assess competitive threats, evaluate technology adoption barriers, and optimize resource allocation for successful market penetration.

      Frequently asked questions

      What is the current size of the US AI in Medical Diagnostics Market?

      The US AI in Medical Diagnostics Market was valued at $588.1 million in 2024 and is projected to reach $1,677.4 million by 2029.

      What is the expected growth rate for the US market through 2029?

      The US market is expected to grow at a compound annual growth rate (CAGR) of 23.3% from 2024 to 2029.

      What are the primary drivers of AI adoption in US medical diagnostics?

      Key drivers include labor shortages in radiology and pathology, demand for early disease detection, strong reimbursement mechanisms, and integration of AI into existing clinical workflows in the US.

      How does the US market compare to global AI diagnostic trends?

      The US market grows at 23.3% CAGR, slightly outpacing the global average of 22.5%, reflecting the region's advanced healthcare infrastructure and regulatory environment.

      Which healthcare settings are driving US AI diagnostic adoption?

      Hospitals, imaging centers, clinical laboratories, and specialty practices across the US are increasingly deploying AI diagnostic solutions to enhance operational efficiency and clinical outcomes.

      RESEARCH METHODOLOGY

      To balance primary and secondary research for the AI in Medical Diagnotics market, different market variables for small and medium-sized businesses and major businesses were analyzed as part of this study. The next step involved primary research with industry experts along the value chain to validate these findings, assumptions, and market sizing. Many different methodologies were used for estimating the overall market size, involving the top-down and bottom-up approaches. The study consists of significant market segments, evolving patterns, regulatory frameworks, and competitive environments. This study also considers leading market players and the strategies they deploy in this market. In conclusion, the total market size was estimated through top-down and bottom-up approaches along with data triangulation to reach the number for the final market size. Primary research was conducted throughout the study to validate and test each hypothesis.

      Secondary Research

      The secondary sources referred to for this research study include publications from government sources, directories, and databases (Dun & Bradstreet, Bloomberg Businessweek, and Factiva, among others) to identify and collect information useful for the technical, market-oriented, and commercial study of AI in medical diagnostics market. Secondary data was collected and analyzed to arrive at the overall size of the global AI in medical diagnostics market, which was validated through primary research.

      Primary Research

      Extensive primary research was conducted after acquiring basic knowledge about the global of AI in medical diagnostics market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as Hospitals, Clinics and Other Healthcare Facilities, Diagnostic laboratories and Diagnostics Imaging Center, Other End Users- Employer Groups and Government Bodies) and supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, and Rest of the world. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

      AI in Medical Diagnostics Market

      Note 1: C-level primaries include CEOs, CFOs, and COOs.

      Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note 3: Companies are classified into tiers based on their total revenues. As of 2022, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      As per the review of prominent companies and their revenue shares, the market size of the global AI in medical diagnostics market was calculated in this report. Key players with significant shares in the market were identified as part of secondary research and their medical diagnostics business revenue was calculated, primaries validated the same. Analyzing the annual and financial reports of the leading market participants was one aspect of secondary research. On the other hand, in-depth interviews with important thought leaders, including directors, CEOs, and marketing executives, were a part of the primary study.

      Both top-down and bottom-up approaches were used to estimate and validate the size of the AI in medical diagnostics market and various other dependent submarkets. The research methodology used to estimate the market size includes the following details:

      • Revenues of individual companies were gathered from public sources and databases
      • The shares of the AI in medical diagnostics market players were gathered from secondary sources to the extent available. In certain cases, the shares of the businesses were ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, selling prices, and geographic reach and strength
      • Individual shares or revenue estimates were validated through expert interviews
      • All percentage shares, splits, and breakdowns for the global AI in medical diagnostics market were determined by using secondary sources and verified through primary sources
      • All key macro indicators affecting the revenue growth of market segments and subsegments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get validated and verified quantitative and qualitative data
      • The gathered market data was consolidated and added with detailed inputs and analysis and presented in this report

      AI in medical diagnostics Market Size: Market Estimation Approach

      AI in Medical Diagnostics Market

      Data Triangulation

      To estimate the overall market size of the AI in medical diagnostics market, a detailed market size estimation process was followed. The market was then segmented into various segments and subsegments for more precise analysis. To ensure accuracy, data triangulation and market breakdown methodologies were applied where applicable. This approach involved analyzing various factors and trends from both the demand and supply sides, providing comprehensive and reliable insights into the market.

      Market Definition

      Artificial intelligence (AI) refers to the theory and development of computer systems capable of performing tasks that usually require human intelligence. AI involves the study & synthesis of intelligent agents—in this case, a computer system. The system perceives its environment and takes appropriate action to maximize success. AI is being developed to create expert systems and improve human intelligence in machines.

      AI is used in the medical diagnostics market to analyze complex data from various imaging modalities and help end users interpret critical data points to diagnose disease conditions.

      Stakeholders

      • Hospitals
      • Diagnostic care centers
      • Diagnostic laboratories
      • Radiologists and radiology clinics
      • Diagnostic imaging AI device manufacturers and suppliers
      • Medical research laboratories
      • Academic medical centers and universities

      Report Objectives

      • To define, describe, and forecast artificial intelligence in the medical diagnostics market based on component, application, end user, and region
      • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments concerning four main regions—North America, Europe, the Asia Pacific, and the Rest of the World (RoW)2
      • To profile the key players and comprehensively analyze their market shares and core competencies
      • To track and analyze competitive developments such as acquisitions, product launches/enhancements, expansions, agreements, collaborations, partnerships, and approvals in AI medical diagnostics market

       

      Get the Full Artificial Intelligence (AI) in Medical Diagnostics Market Report

      Full forecast, segment splits, and company analysis for all Artificial Intelligence (AI) in Medical Diagnostics Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status